Literature DB >> 9257819

IL-12 production by central nervous system microglia is inhibited by astrocytes.

F Aloisi1, G Penna, J Cerase, B Menéndez Iglesias, L Adorini.   

Abstract

IL-12, a 75-kDa heterodimeric cytokine composed of two chains (p35 and p40), is a central regulator of immune responses and may be implicated in the pathogenesis of certain inflammatory diseases of the central nervous system (CNS). We have examined the capacity of two CNS APC, microglia and astrocytes, to produce IL-12 upon stimulation with cytokines, LPS, or a neurotropic virus. In purified microglial cultures from neonatal mouse brains, expression of IL-12 p35 and p40 mRNA is induced by LPS and is stimulated maximally by combined IFN-gamma/LPS treatment, as detected by semiquantitative reverse-transcriptase PCR. LPS induces secretion of IL-12 p40, but not of IL-12 p75, as detected by specific ELISA. Combined stimulation with IFN-gamma/LPS enhances IL-12 p40 secretion and induces IL-12 p75 secretion by microglia. Conversely, mouse astrocytes do not express IL-12 p35 mRNA and do not secrete IL-12 p75 under any condition tested. IL-12 production by activated microglia is inhibited by IL-10, PGE2, and cAMP-elevating agents. Coculture of microglia with astrocytes or exposure of microglia to astrocyte-conditioned medium also results in marked reduction of IL-12 p75 and p40 secretion by IFN-gamma/LPS-stimulated microglia, indicating a regulatory role of astrocytes on IL-12 production. This novel mechanism of IL-12 regulation may play an important role in the control of immune responses during infection or in Th1 cell-mediated autoimmune diseases of the CNS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257819

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

Review 1.  Neurochemistry of brain neuroendocrine immune system: signal molecules.

Authors:  A Galoyan
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 2.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 3.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

Review 4.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Age-associated alterations in the time-dependent profile of pro- and anti-inflammatory proteins within the hippocampus in response to acute exposure to interleukin-1β.

Authors:  Sarah C Hopp; Sarah Royer; Holly M Brothers; Roxanne M Kaercher; Heather D'Angelo; Isabelle Bardou; Gary L Wenk
Journal:  J Neuroimmunol       Date:  2013-12-22       Impact factor: 3.478

Review 6.  Immune players in the CNS: the astrocyte.

Authors:  Cathy J Jensen; Ann Massie; Jacques De Keyser
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-04       Impact factor: 4.147

Review 7.  The multifaceted profile of activated microglia.

Authors:  Marina A Lynch
Journal:  Mol Neurobiol       Date:  2009-07-23       Impact factor: 5.590

Review 8.  Cytokines in the brain during viral infection: clues to HIV-associated dementia.

Authors:  D E Griffin
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

Review 9.  Neural-immune interactions in health and disease.

Authors:  E M Sternberg
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

Review 10.  Transgenic models for cytokine-induced neurological disease.

Authors:  Iain L Campbell; Markus J Hofer; Axel Pagenstecher
Journal:  Biochim Biophys Acta       Date:  2009-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.